These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30733324)

  • 1. Evaluation of
    Nabulsi NB; Holden D; Zheng MQ; Bois F; Lin SF; Najafzadeh S; Gao H; Ropchan J; Lara-Jaime T; Labaree D; Shirali A; Slieker L; Jesudason C; Barth V; Navarro A; Kant N; Carson RE; Huang Y
    J Nucl Med; 2019 Aug; 60(8):1147-1153. PubMed ID: 30733324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-in-Human Assessment of
    Naganawa M; Nabulsi N; Henry S; Matuskey D; Lin SF; Slieker L; Schwarz AJ; Kant N; Jesudason C; Ruley K; Navarro A; Gao H; Ropchan J; Labaree D; Carson RE; Huang Y
    J Nucl Med; 2021 Apr; 62(4):553-560. PubMed ID: 32859711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Kappa Opioid Receptor Agonist as Improved PET Radiotracer: Development and in Vivo Evaluation.
    Li S; Zheng MQ; Naganawa M; Gao H; Pracitto R; Shirali A; Lin SF; Teng JK; Ropchan J; Huang Y
    Mol Pharm; 2019 Apr; 16(4):1523-1531. PubMed ID: 30726092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.
    Nabulsi NB; Mercier J; Holden D; Carré S; Najafzadeh S; Vandergeten MC; Lin SF; Deo A; Price N; Wood M; Lara-Jaime T; Montel F; Laruelle M; Carson RE; Hannestad J; Huang Y
    J Nucl Med; 2016 May; 57(5):777-84. PubMed ID: 26848175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
    Chen L; Nabulsi N; Naganawa M; Zasadny K; Skaddan MB; Zhang L; Najafzadeh S; Lin SF; Helal CJ; Boyden TL; Chang C; Ropchan J; Carson RE; Villalobos A; Huang Y
    J Nucl Med; 2016 Sep; 57(9):1448-53. PubMed ID: 27199356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Pharmacological Characterization and In Vivo Validation of LSN3172176 a Novel M1 Selective Muscarinic Receptor Agonist Tracer Molecule for Positron Emission Tomography.
    Mogg AJ; Eessalu T; Johnson M; Wright R; Sanger HE; Xiao H; Crabtree MG; Smith A; Colvin EM; Schober D; Gehlert D; Jesudason C; Goldsmith PJ; Johnson MP; Felder CC; Barth VN; Broad LM
    J Pharmacol Exp Ther; 2018 Jun; 365(3):602-613. PubMed ID: 29643252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel
    Li S; Cai Z; Zheng MQ; Holden D; Naganawa M; Lin SF; Ropchan J; Labaree D; Kapinos M; Lara-Jaime T; Navarro A; Huang Y
    J Nucl Med; 2018 Jan; 59(1):140-146. PubMed ID: 28747521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Search for a Subtype-Selective PET Imaging Agent for the GABA
    Lin SF; Bois F; Holden D; Nabulsi N; Pracitto R; Gao H; Kapinos M; Teng JK; Shirali A; Ropchan J; Carson RE; Elmore CS; Vasdev N; Huang Y
    Mol Imaging; 2017; 16():1536012117731258. PubMed ID: 28929924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET Imaging Estimates of Regional Acetylcholine Concentration Variation in Living Human Brain.
    Smart K; Naganawa M; Baldassarri SR; Nabulsi N; Ropchan J; Najafzadeh S; Gao H; Navarro A; Barth V; Esterlis I; Cosgrove KP; Huang Y; Carson RE; Hillmer AT
    Cereb Cortex; 2021 May; 31(6):2787-2798. PubMed ID: 33442731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization in nonhuman primates of (R)-[
    Zheng M; Ahmed H; Smart K; Xu Y; Holden D; Kapinos M; Felchner Z; Haider A; Tamagnan G; Carson RE; Huang Y; Ametamey SM
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2153-2162. PubMed ID: 35107627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Improved Antagonist Radiotracer for the κ-Opioid Receptor: Synthesis and Characterization of (11)C-LY2459989.
    Zheng MQ; Kim SJ; Holden D; Lin SF; Need A; Rash K; Barth V; Mitch C; Navarro A; Kapinos M; Maloney K; Ropchan J; Carson RE; Huang Y
    J Nucl Med; 2014 Jul; 55(7):1185-91. PubMed ID: 24854795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics.
    Li S; Zheng MQ; Naganawa M; Kim S; Gao H; Kapinos M; Labaree D; Huang Y
    J Nucl Med; 2019 Jul; 60(7):1023-1030. PubMed ID: 30630942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates.
    Hillmer AT; Zheng MQ; Li S; Scheunemann M; Lin SF; Holden D; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Carson RE; Brust P; Huang Y
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):537-47. PubMed ID: 26455500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evaluation of [11C]MP-10 as a radiotracer for phosphodiesterase 10A: PET imaging study in rhesus monkeys and brain tissue metabolite analysis.
    Lin SF; Labaree D; Chen MK; Holden D; Gallezot JD; Kapinos M; Teng JK; Najafzadeh S; Plisson C; Rabiner EA; Gunn RN; Carson RE; Huang Y
    Synapse; 2015 Feb; 69(2):86-95. PubMed ID: 25450608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical Evaluation and Nonhuman Primate Receptor Occupancy Study of
    Kolb HC; Barret O; Bhattacharya A; Chen G; Constantinescu C; Huang C; Letavic M; Tamagnan G; Xia CA; Zhang W; Szardenings AK
    J Nucl Med; 2019 Aug; 60(8):1154-1159. PubMed ID: 30733317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging.
    Zheng MQ; Nabulsi N; Kim SJ; Tomasi G; Lin SF; Mitch C; Quimby S; Barth V; Rash K; Masters J; Navarro A; Seest E; Morris ED; Carson RE; Huang Y
    J Nucl Med; 2013 Mar; 54(3):455-63. PubMed ID: 23353688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET Imaging Evaluation of Four σ
    Baum E; Cai Z; Bois F; Holden D; Lin SF; Lara-Jaime T; Kapinos M; Chen Y; Deuther-Conrad W; Fischer S; Dukic-Stefanovic S; Bunse P; Wünsch B; Brust P; Jia H; Huang Y
    J Nucl Med; 2017 Jun; 58(6):982-988. PubMed ID: 28232607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic Modeling and Test-Retest Reproducibility of
    Naganawa M; Li S; Nabulsi N; Lin SF; Labaree D; Ropchan J; Gao H; Mei M; Henry S; Matuskey D; Carson RE; Huang Y
    J Nucl Med; 2020 Nov; 61(11):1636-1642. PubMed ID: 32169917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 11C-BU99008, a PET ligand for the imidazoline2 binding sites in rhesus brain.
    Parker CA; Nabulsi N; Holden D; Lin SF; Cass T; Labaree D; Kealey S; Gee AD; Husbands SM; Quelch D; Carson RE; Nutt DJ; Huang Y; Tyacke RJ
    J Nucl Med; 2014 May; 55(5):838-44. PubMed ID: 24711648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates.
    Bois F; Gallezot JD; Zheng MQ; Lin SF; Esterlis I; Cosgrove KP; Carson RE; Huang Y
    Nucl Med Biol; 2015 Jun; 42(6):570-7. PubMed ID: 25858513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.